Texas A&M Football

Around Aggieland (9/24)

On Wednesday's edition of TexAgs Live, Kaylee Dreyer took us Around Aggieland as Texas A&M football received its conference opponents for the next four seasons. Also, volleyball begins SEC play, soccer searches for its first conference win and more.
September 24, 2025
1.7k Views
Discuss
Story Poster

Football
The SEC announced Texas A&M's opponents for conference games from 2026 through 2029.

It will be a nine-game schedule beginning next season, and each school will play every other SEC school at least once every two years, and play every opponent home and away over the four years. Some notable opponents for the Aggies include playing Oklahoma in 2026 for the first time since the 2012 Cotton Bowl and hosting Georgia in 2027 for the first time in SEC history.

Volleyball
The No. 13 Texas A&M volleyball team begins SEC play tonight, hosting No. 21 Missouri at Reed Arena with the first serve set for 6 p.m. They concluded their non-conference schedule, sweeping Southeastern Louisiana, New Hampshire and Loyola Marymount. The Aggies didn't drop a single set and outscored opponents 225-151 over the three matches.

Soccer
Texas A&M soccer dropped to 0-3 in SEC play and 3-4-3 on the season as they came up short against the No. 10 Arkansas Razorbacks, losing 1-0. The Aggies look to bounce back, taking on yet another top 10-ranked opponent as they travel to Knoxville to play No. 5 Tennessee.

Men’s Tennis
Alex Frusina
and Kholo Montsi are competing in the ITA All-American Championships as the singles and double main draw begin today. Frusina began his tournament run in the singles main draw against Corey Craig from Florida State at 9 a.m. this morning, and Montsi will join him in the doubles draw later today.

Discuss
Discussion from...

Around Aggieland (9/24)

936 Views | 0 Replies | Last: 1 mo ago by kayleedreyer
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.